Table 1 Baseline characteristics and clinical data after hospitalization of study population.
Variables | Total (n = 374) | 28-day survival (n = 254) | 28-day mortality (n = 120) | p-Value |
---|---|---|---|---|
Demographic data | ||||
Sex, male, n (%) | 244 (65%) | 157 (62%) | 87 (73%) | 0.043* |
Age (years) | 72 (64, 83) | 70 (60, 78) | 82 (72, 88) | < 0.001* |
Co-morbidities | ||||
Hypertension, n (%) | 183 (49%) | 113 (44%) | 70 (58%) | 0.012* |
Diabetes mellitus, n (%) | 110 (29%) | 67 (26%) | 43 (36%) | 0.061 |
Coronary heart disease, n (%) | 75 (20%) | 49 (19%) | 26 (22%) | 0.592 |
Cerebrovascular disease, n (%) | 33 (8.8%) | 20 (7.9%) | 13 (10.8%) | 0.346 |
COPD, n (%) | 38 (10.2%) | 23 (9.1%) | 15 (12.5%) | 0.309 |
Liver disease, n (%) | 33 (8.8%) | 25 (9.8%) | 8 (6.7%) | 0.312 |
Malignant tumor, n (%) | 42 (11%) | 28 (11%) | 14 (12%) | 0.854 |
Vital signs | ||||
Body temperature, ℃ | 36.7 (36.3,37.0) | 36.6 (36.2,37.0) | 36.7 (36.5,37.2) | 0.033* |
RR, breaths/min | 21 (20,23) | 20 (20,22) | 23 (23,28) | < 0.001* |
HR, beats/min | 88 (78,100) | 85 (78,97.8) | 94 (82.8,106.3) | < 0.001* |
SBP, mmHg | 131 (120,145) | 130 (120,144) | 132 (119,149) | 0.913 |
Arterial blood gas | ||||
PH | 7.439 (7.402,7.466) | 7.432 (7.401,7.460) | 7.452(7.408,7.480) | 0.010* |
PaCO2, mmHg | 34.2 (29.5,39.2) | 35.8 (31.5,39.6) | 29.9 (26.7,34.7) | < 0.001* |
PaO2, mmHg | 83.2 (65.6,104.4) | 91.2 (73.6,107.6) | 67.1 (57.1,86.4) | < 0.001* |
SpO2, % | 97.0 (94.0,99.0) | 97.8 (95.3,99.0) | 94.5 (90.5,97.1) | < 0.001* |
PaO2/FiO2, mmHg | 282 (207,330) | 290 (232,333) | 115 (70,215) | < 0.001* |
COVID-19 severity class, n (%) | < 0.001* | |||
Mild illness | 90 (24%) | 86 (34%) | 4 (3.3%) | |
Moderate illness | 117 (31%) | 111 (44%) | 6 (5.0%) | |
Severe/critical illness | 167 (45%) | 57 (22%) | 110 (92%) | |
Clinical scoring system | ||||
PIRO | 9 (5,14) | 7 (4,10) | 14 (12,17) | < 0.001* |
qSOFA | 0 (0,1) | 0 (0,1) | 2 (1,2) | < 0.001* |
CURB-65 | 1 (1,2) | 1 (1,2) | 3 (2,3) | < 0.001* |
PSI | 91 (71,115) | 84 (63,101) | 118 (94.140) | < 0.001* |
COVID-GRAM | 160 (124,188) | 138 (110,165) | 193 (179,214) | < 0.001* |
RAPS | 3 (1,5) | 1 (1,3) | 5 (3,6) | < 0.001* |
NEWS2 | 5 (3,8) | 4 (2,6) | 9 (6,11) | < 0.001* |
Laboratory parameters | ||||
PCT, ng/mL | 0.11 (0.05,0.4) | 0.07 (0.05,0.178) | 0.35 (0.12,1.03) | < 0.001* |
CRP, mg/L | 44.0 (10.0,79.3) | 22.0 (5.7,56.6) | 79.3 (54.8,107.5) | < 0.001* |
HGB, g/L | 124 (107,138) | 124 (107,138) | 123 (112,137) | 0.984 |
WBC count, ×109/L | 6.11 (4.37,9.45) | 5.31 (3.93,7.69) | 8.57 (5.89,11.08) | < 0.001* |
Neutrophils count, ×109/L | 4.66 (2.80,7.62) | 3.70 (2.48,6.30) | 7.02 (4.77,9.77) | < 0.001* |
Lymphocytes count, ×109/L | 0.83 (0.55,1.11) | 0.93 (0.65,1.23) | 0.63 (0.38,0.94) | < 0.001* |
INR | 1.09 (1.03,1.18) | 1.07 (1.02,1.16) | 1.12 (1.04,1.20) | 0.004* |
D-dimer, mg/L | 352 (143,1040) | 244 (76,490) | 1159 (446,4347) | < 0.001* |
ALT, U/L | 22 (16,33) | 21 (14,31) | 26 (19,37) | < 0.001* |
AST, U/L | 30 (20,48) | 27 (19,38) | 46 (31,71) | < 0.001* |
Albumin, g/L | 33.0 (28.1,36.5) | 34.8 (30.8,37.5) | 27.9 (25.3,31.9) | < 0.001* |
TBIL, µ mol/L | 10.9 (8.0,15.7) | 10.4 (7.7,15.1) | 11.8 (8.5,16.8) | 0.067 |
DBIL, µ mol/L | 4.7 (3.0,7.6) | 4.1 (2.8,6.5) | 6.2 (4.2,9.35) | < 0.001* |
CAR | 1.159 (0.219,2.745) | 0.576 (0.130,1.712) | 2.874 (1.657,3.762) | < 0.001* |
BCDIMs | ||||
NLR | 5.91 (3.10,11.75) | 4.11 (2.41,8.03) | 11.71 (6.82,20.1) | < 0.001* |
PLR | 194 (127,322) | 174 (117,264) | 294 (168,434) | < 0.001* |
LCR | 0.02 (0.008,0.099) | 0.040 (0.013,0.183) | 0.008 (0.005,0.015) | < 0.001* |
SII | 1052 (404,3617) | 666 (326,1824) | 2964 (1347,8035) | < 0.001* |